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Abstract
Aims This study aimed at evaluating the potential
anti-proliferative eVects of the microRNA let-7 family in
nasopharyngeal carcinoma (NPC) cells. In addition, the
association between let-7 suppression and DNA hyperme-
thylation is examined.
Materials and methods Levels of mature let-7 family
members (-a, -b, -d, -e, -g, and -i) in normal nasopharyn-
geal cells (NP69 and NP460) and nasopharyngeal carci-
noma cells (HK1 and HONE1) were measured by real-time
quantitative PCR. Cell-proliferation assay and c-Myc
immunohistochemical staining were performed on NPC
cells transfected with let-7 precursor molecules. In addi-
tion, expression changes in let-7 family members in
response to demethylating agents (5-azacytidine and zebul-
arine) were also examined.
Results In comparison with the normal nasopharyngeal
cells, let-7 (-a, -b, -d, -e, -g, and -i) levels were reduced in
nasopharyngeal carcinoma cells. Ectopic expression of the
let-7 family in nasopharyngeal carcinoma cells resulted in
inhibition of cell proliferation through downregulation of
c-Myc expression. Demethylation treatment of nasopharyn-
geal carcinoma cells caused activation of let-7 expression in
poorly diVerentiated nasopharyngeal carcinoma cells only.
Conclusion Our results suggested that miRNA let-7
might play a role in the proliferation of NPC. DNA methyl-
ation is a potential regulatory pathway, which is aVected
when let-7 is suppressed in NPC cells. However, the extent
of DNA hypermethylation/hypomethylation in regulating
let-7 expression requires further elucidation.
Keywords MicroRNAs · Let-7 · Proliferation · 
Nasopharyngeal carcinoma · Epigenetic regulation
Introduction
MicroRNAs (miRNAs) are endogenous non-coding RNA
molecules (18–25 nucleotides in length), which function
as post-transcriptional modulators (Cullen 2004). MiR-
NAs are expressed as long precursor RNAs. After processing
by nuclease, the miRNAs are actively transported into cyto-
plasm through exportin-5-dependent mechanism. Cytoplasmic
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miRNAs become functionally mature after further process-
ing by cellular nuclease Dicer. Mature miRNAs are associ-
ated with a cellular complex analogous to the RNA-induced
silencing complex that participates in RNA interference
(Hutvagner and Zamore 2002). The imperfect complemen-
tary binding of miRNA to mRNA could promote degrada-
tion of the mRNA molecule and/or hindering the translation
process. In addition, the partial complementary binding of
the miRNA to the mRNA could enhance poly (A) tail removal
and thus accelerate mRNA degradation (Wu et al. 2006).
Nasopharyngeal carcinoma (NPC) is a common head
and neck cancer. High incidence of NPC is observed in
Southern China. In our locality, undiVerentiated carcinoma
is the most prevalent NPC histology (Wei and Sham 2005).
NPC is a multi-factorial disease. Genetic predisposition
(Dittmer et al. 2008) and epigenetic alterations (Wong et al.
2004) are signiWcant in the initiation and progression of
NPC. In addition, the pathogenesis of NPC is closely linked
to Epstein–Barr virus infection. Tobacco and alcohol con-
sumption are critical risk factors as well (Chang and Adami
2006). Recently, it has been shown that miRNA dysregula-
tion is implicated in the carcinogenesis of many human
cancers. In cancer cells, the upregulated/downregulated
miRNA could function as oncogenic/tumor-suppressing
modulators. In case of NPC, however, the critical miRNA
changes involved in its carcinogenesis are not yet clearly
deWned (Chen et al. 2009; Sengupta et al. 2008).
In this study, we investigated the potential involvement
of miRNA let-7 in NPC. We showed that NPC cells have
lower let-7 levels in comparison with normal nasopharyn-
geal epithelial cells. To determine whether the reduced let-7
levels have a causative role in NPC, let-7 precursor mole-
cules were re-introduced to the NPC cells. It was found that
let-7 could reduce cell proliferation through downregula-
tion of c-Myc. In view of the fact that several let-7 family
members are located in CpG islands, we suggested that
CpG island methylation is a potential mechanism involved
in let-7 suppression in cancer cells. We therefore assessed
whether demethylation treatment could elevate the tran-
script levels of let-7 in NPC cells.
Materials and methods
Cell lines and drugs
NPC cell lines (HK1 and HONE1) and normal nasopharyn-
geal-derived epithelial cells (NP69 and NP460) were used
in the present study. All the nasopharyngeal cells were pro-
vided by Professor SW Tsao (Department of Anatomy, The
University of Hong Kong). HK1 is derived from well-
diVerentiated squamous carcinoma (Huang et al. 1980);
HONE1 is derived from poorly diVerentiated squamous
carcinoma (Glaser et al. 1989). NPC cell lines were main-
tained in Roswell Park Memorial Institute (RPMI) 1640
medium supplemented with 10% FBS; normal nasopharyn-
geal-derived epithelial cells were maintained in keratino-
cyte serum-free medium. Demethylating agents zebularine
and 5-azacytidine were obtained from Sigma–Aldrich, St.
Louis, MO, USA. In drug treatments, the demethylating
agents were diluted to appropriate concentration with
RPMI 1640. Analysis was performed after 48-h treatment.
RNA extraction
MiRNA extraction was performed using mirVanaTM
miRNA Isolation Kit (Ambion, Austin, TX) following the
manufacturer’s instructions.
QuantiWcation of mature miRNA
Individual Taqman-based real-time PCR assays for miRNA
let-7a (Assay ID: 000377; target sequence: UGAGGUAGU
AGGUUGUAUAGUU), -7b (Assay ID: 000378; target
sequence: UGAGGUAGUAGGUUGUGUGGUU), -7d
(Assay ID:000380; target sequence: AGAGGUAGUAGG
UUGCAUAGU), -7e (Assay ID:000381; target sequence:
UGAGGUAGGAGGUUGUAUAGU), -7g (Assay ID:
000383; target sequence: UGAGGUAGUAGUUUGUAC
AGU), and -7i (Assay ID: 000384; target sequence: UGA
GGUAGUAGUUUGUGCUGU) were obtained from
Applied Biosystems, CA, USA. Real-time PCR was per-
formed using GeneAmp® Fast PCR Master Mix (Applied
Biosystems, CA, USA) and ABI 7900HT real-time PCR
machine. All reactions were performed in triplicate. Rela-
tive expression levels of mature miRNAs were evaluated
using comparative Ct method (Livak and Schmittgen
2001). For comparison of miRNA levels between diVerent
nasopharyngeal cell lines, 2¡Ct method was used. BrieXy,
transcript levels of target miRNA and housekeeping
miRNA was derived from the cycle threshold (Ct) based on
the ampliWcation eYciency. The Ct of the target miRNA
was normalized to the internal reference miRNA miR-16.
Ct (Ct target miRNA ¡ Ct miR-16) was calculated to nor-
malize the input miRNA levels between samples. The
respective 2¡Ct data were then calculated from the Ct.
For comparing miRNA levels between the transfected
nasopharyngeal cell lines and the mock control, 2¡Ct
method was adopted. Here, Ct refers to [(Ct target
miRNA) ¡ (Ct miR16)] transfected cell ¡ [(Ct target
miRNA) ¡ (Ct miR16)] mock control.
Transfection of let-7 precursors
Let-7a, -7b, -7d, -7e, -7g, and -7i precursors were obtained
from Ambion. Precursor molecules were transfected intoJ Cancer Res Clin Oncol (2011) 137:415–422 417
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the culture cells using siPORTTM NeoFXTM reagent
(Ambion, Austin, TX) according to the manufacturer’s
instructions. The medium was changed after 24 h and sam-
ples were analyzed after 72 h. For each precursor,
transfection was performed in duplicate. Cells treated
with the transfection reagent only were used as mock con-
trol. To test the transfection eYciency, parallel transfec-
ted cells were collected and the changes in mature let-7
levels were measured by real-time quantitative PCR
again. The transfected cells with more than 50-fold
increase in let-7 transcript levels will be used in subse-
quent analysis.
Cell-proliferation assay
Changes in proliferation rate were evaluated using CellT-
iter 96 AQueous One Solution Cell Proliferation Assay
(Promega, Madison, WI, USA) according to the manufac-
turer’s protocol. Cells were cultured on 96-well plate with
10,000 cells in each well. Proliferation rate was examined
after 24 h. Absorbance was read by Xuorescence microplate
Reader (Model 680, Bio-Rad Laboratory, CA, USA) at
595 nm. All samples were examined in triplicate.
Immunohistochemistry
BrieXy, culture cells were washed with PBS and Wxed with
2% paraformaldehyde overnight. Mouse anti-c-Myc anti-
body (Santa Cruz, CA, USA) was used as primary antibody
at 1:200 dilutions. Goat anti-mouse antibody conjugated
with FITC (Santa Cruz, CA, USA) was used as secondary
antibody at 1:100 dilutions. The nuclei were counterstained
with DAPI. Slides were observed and analyzed with the
image analysis system (Nikon eclipse 80i Xorescent micro-
scope (Nikon, Tokyo, Japan).
Statistical analysis
Data analysis was performed using SPSS® for Windows
version 14.0. Quantitative results were compared with
paired t-test. All p-values were two-sided. P-values ·0.05
were considered as statistically signiWcant.
Results
MiRNA let-7 family was signiWcantly reduced 
in nasopharyngeal carcinoma cells
To identify the potential tumor-suppressing miRNA in
NPC cells, we Wrst performed miRNA expression proWling
on the NPC cells (HK1 and HONE1) and compared the
results with the miRNA expression patterns of normal
nasopharyngeal-derived epithelial cells (NP69 and NP460).
It was found that the levels of miRNA let-7 family (let-7a,
-7b, -7d, -7e, -7g, and -7i) were consistently reduced in NPC
cells in comparison with the normal epithelial cells (Fig. 1).
Morphological changes in NPC cell lines (HK1 
and HONE1) in response to the introduction 
of let-7 precursor molecules
To elucidate the functional role of let-7 in NPC cells, we
introduced the let-7 precursor molecules into the NPC cells
and observed the resultant morphological changes. Let-7a,
-7b, -7d, -7e, -7g, and -7i precursors were introduced into
the NPC cells lines individually. The cultures were moni-
tored continuously under light microscopy for 3 days after
transfection. We did not notice any signiWcant changes in
size and morphology of the cancer cells. However, the cell
numbers in the transfected groups were signiWcantly
reduced in comparison with the mock control. Morphologi-
cally, the transfected cells were similar to the mock control
(Fig. 2).
Reduced proliferation rate in let-7 precursor transfected 
NPC cells
We measured the changes in proliferation propensity of the
NPC cells in response to the addition of precursor mole-
cules. Each of the six let-7 precursor molecules could
reduce the proliferation rate of both HONE1 and HK1 cells
individually (Fig. 3).
Fig. 1 Mature let-7 miRNA expression is reduced in NPC cells (HK1
and HONE1) in comparison with normal nasopharyngeal cells (NP69
and NP460). Expression levels of mature let-7 (-a, -b, -d, -e, -g, and
-i) was evaluated using the comparative threshold cycle method
(2¡CT). Transcript miR-16 levels were used as endogenous control.
All tests were performed in triplicate. The data were expressed as
mean value with standard deviations418 J Cancer Res Clin Oncol (2011) 137:415–422
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Reduced c-Myc expression in NPC cells in response 
to let-7 precursor
We measured the c-Myc levels in the cell lines after trans-
fection with let-7 precursor molecules. Reduction in c-Myc
protein level was observed in all the transfected cell lines
(Fig. 4).
Upregulation of let-7 by demethylating agents (zebularine 
and 5-azacytidine)
To validate the association of let-7 downregulation and
aberrant CpG island methylation in NPC cells, the let-7
family members levels were measured in the cell lines after
demethylation treatment. In HONE1, administration of
Fig. 2 Reduced NPC cells num-
ber in response to ectopic let-7 
expression. NPC cell lines HK1 
(a) and HONE1 (b) were trans-
fected with let-7 precursors. 
Morphological changes 
were monitored under light 
microscopyJ Cancer Res Clin Oncol (2011) 137:415–422 419
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either 5-azacytidine or zebularine would result in upregula-
tion of mature let-7 expression. Concentration-dependent
eVects were observed. In comparison with 5-azacytidne,
zebularine was more potent in activating let-7 expression.
At same IC, zebularine could induce a higher increase in
let-7 expression.
In contrast, neither zebularine nor 5-azacytidine was
eVective in upregulating let-7 expression in HK1. In the
HK1 cell line, let-7 expression was mostly reduced in
response to demethylation treatment. Only a slight increase
in let-7-a, -b, -d, and -e expression was observed when a
high dose of zebularine was administered (Fig. 5).
Discussion
Let-7 is a family of tumor-suppressing miRNAs and its
expression is reduced in the majority of human malignan-
cies. High level of let-7 expression has an anti-proliferative
eVect on cancer cells. In head and neck squamous cell car-
cinoma, it has been reported that low let-7d expression is a
prognostic factor for poor survival (Childs et al. 2009).
Conversely, in cancers such as breast, lymphoma, and ovarian
cancers, several let-7 members are upregulated (Boyerinas
Fig. 3 Let-7 inhibits NPC cell proliferation. NPC cells (HK1 and
HONE1) were transfected with let-7 (-a, -b, -d, -e, -g, and -i) precur-
sors, and the proliferation rate were measured with MTS assay after
72 h. All tests were performed in triplicate. The data were expressed as
mean value with standard deviations. ** P < 0.001, * P <0 . 0 5
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Fig. 4 Let-7 downregulates c-
Myc expression in NPC cells 
(HONE1 and HK1). NPC cells 
(HK1 and HONE1) were trans-
fected with let-7 (-a, -b, -d, -e, 
-g, and -i) precursors. After 72 h, 
the transfected cells were exam-
ined by immunohistochemical 
staining using monoclonal 
c-Myc antibody. Reduced 
c-Myc protein levels were 
observed in NPC cells with 
ectopic expression of let-7 
family members420 J Cancer Res Clin Oncol (2011) 137:415–422
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Fig. 5 Let-7 expression chang-
es in response to 5-azacytidine 
and zebularine. NPC cells were 
treated with the demethylation 
agents separately, and the 
changes in let-7 members’ 
expression were measured after 
48 h of treatment. Left panel: 
expression changes in let-7 in 
HONE1; right panel: expression 
changes in let-7 in HK1. 
** P < 0.001, * P <0 . 0 5
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et al. 2010). In view of the conXicting expression patterns
across human cancers, we Wrst tested the expression levels
of let-7 in NPC and normal nasopharyngeal cells. The naso-
pharyngeal cultures (both NPC and normal nasopharyngeal
cells) we tested expressed all the six let-7 family members.
We observed substantially lower let-7 levels in NPC cells
(HK1 and HONE1) in comparison with the normal naso-
pharyngeal-derived epithelial cells (NP69 and NP460). We
therefore hypothesized that the low let-7 may contribute to
the high proliferation rate of NPC cells.
To test the potential anti-proliferative eVects of let-7 in
NPC cells, we transfected the NPC cells with let-7 precur-
sor molecules individually. The precursors molecules are
processed by the NPC cells and become structurally and
functionally mature in the cytoplasm after transfection. All
the let-7 family members we tested demonstrated anti-pro-
liferative eVect on both HK1 and HONE1 cells. The eVects
are obvious, and the reduction in the total cell number of
the transfected cells is noticed by visual inspection under
light microscope. To conWrm the results, cell-proliferation
assay was performed. Among all the let-7 family members,
let-7g is most eVective in reducing the proliferative activity
of both HK1 and HONE1 cells.
To conWrm the linkage between let-7 and the reduction
in proliferation rate observed in the let-7-transfected cells,
immunohistochemical staining on the let-7 target gene c-Myc
was carried out. c-Myc is an oncogene involved in prolifer-
ation of NPC cells (Wang et al. 2007). Ninety percent NPC
tissues demonstrated c-Myc expression (Porter et al. 1994).
c-Myc could activate transcription of human reverse
telomerase transcriptase (hTERT) and thereby promote
proliferation and immortalization (Kirkpatrick et al. 2003).
Recent studies also revealed that c-Myc is regulated by the
let-7 family (Sampson et al. 2007). Let-7 can downregulate
c-Myc expression in several cancers such as colon cancer
(Akao et al. 2006). We therefore suggested that high let-7
levels would have a suppressive eVect on c-Myc expres-
sion. The reduced c-Myc protein levels in response to the
ectopic expression of let-7 precursor suggested that let-7
has a role in regulating proliferation through the downregu-
lation of c-Myc expression in NPC cells.
So far, the way in which let-7 expression is suppressed
in NPC cells is not clear. Recent studies revealed that geno-
mic region of several let-7 family members is associated
with CpG islands (Lu et al. 2007). Thus, CpG island hyper-
methylation/hypomethylation may be a regulatory mecha-
nism. If the reduced let-7 levels observed in our NPC cells
is associated with CpG island hypermethylation, demethyl-
ation treatment would be eVective in elevating let-7 tran-
script levels in NPC cells. Since members of the let-7
family are sequentially and functionally similar, suppress-
ing single-member expression would not have signiWcant
contributory eVects in NPC cells. If hypermethylation is a
critical mechanism in inactivating the functional role of
let-7 in NPC, concurrent epigenetic inactivation of the let-7
family member should be observed.
Thus, we treated the NPC cells with demethylating
agents, 5-azacytidine and zebularine, and monitored the
expression changes in let-7 after demethylation treatment.
The two demethylating agents we used are cytosine ana-
logs. They are incorporated into the newly synthesized
DNA strand during mitosis. These cytosine analogs could
bind to cytosine-C5 DNA methyltransferase covalently and
alter the de novo addition of methyl group on their cytosine
ring (Marquez et al. 2005; O’Dwyer and Maslak 2008).
Both drugs alter the formation of methyl cytosine on the
newly divided cancer cells and so render DNA demethyla-
tion passively.
In general, let-7 expression is upregulated in HONE1
cells, which is derived from poorly diVerentiated NPC,
after demethylation treatment. Both 5-azacytidine and
zebularine could upregulate let-7 members’ expression in
HONE1 cells. Zebularine is more potent in upregulating
transcription of let-7 family members. Interestingly, HK1,
derived from well-diVerentiated NPC, behaves diVerently
in comparison with HONE1 (derived from poorly diVer-
entiated NPC). Treatment of HK1 with 5-azacytidine and
zebularine (low dose, IC30) has a suppressing eVect on
transcription of let-7 members. Upregulation of let-7 tran-
scription is only observed when high-dose (IC50) zebular-
ine was used. A slight increase in let-7-a, -b, -d, and -e
levels was observed when HONE1 was exposed to zebul-
arine at relatively high concentration. At this moment, we
have no explanation on the distinctively diVerent
responses of these two NPC cell lines to demethylating
agents. We cannot exclude the possibility that let-7
expression is regulated by CpG island methylation in
NPC. It seems that poorly diVerentiated NPC cells are
more sensitive to the demethylating agents in comparison
with well-diVerentiated NPC cells. Apparently, CpG
island hypermethylation/hypomethylation alone could not
fully explain the aberrant dysregulation of let-7 family
members in NPC cells.
In conclusion, similar to other human malignancies, let-7
has an anti-proliferative eVect on NPC cells and this is
partly carried out through its suppressing eVect on c-Myc
expression. The family members of let-7 in NPC cells are
responsive to demethylating agents. However, the diVeren-
tiation status of NPC cells may aVect the response of NPC
cells to demethylating agents with regard to their let-7
expression. The diVerent responses of NPC cells to the
demethylating agents suggest that the epigenetic regulatory
mechanism of let-7 is not a common process across diVer-
ent types of NPC. It is of great interest to elucidate the reg-
ulatory mechanisms and functional role of let-7 in NPC
carcinogenesis. Further studies are warranted to answer422 J Cancer Res Clin Oncol (2011) 137:415–422
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whether demethylation treatment is a suitable regime to
restore the dysregulated let-7 expression in NPC.
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